Sign Out
No data are available on overdosage. Patients with incompatible transfusion who receive an overdose of human anti-D (Rh) immunoglobulin should be monitored clinically and by biological parameters, because of the risk of haemolytic reaction.
In other Rh(D) negative individuals overdosage should not lead to more frequent or more severe undesirable effects than the normal dose.
Continue with Google